Mayo score - Revision history

Michael: UC -> to IBD

2023-04-05T14:53:29Z

UC -> to IBD

← Older revision		Revision as of 14:53, 5 April 2023
Line 1:		Line 1:
	'''Mayo score''' is used by some endoscopists to grade [[~~ulcerative colitis~~]] activity.<ref name=pmid26071941>{{Cite journal \| last1 = Peyrin-Biroulet \| first1 = L. \| last2 = Panés \| first2 = J. \| last3 = Sandborn \| first3 = WJ. \| last4 = Vermeire \| first4 = S. \| last5 = Danese \| first5 = S. \| last6 = Feagan \| first6 = BG. \| last7 = Colombel \| first7 = JF. \| last8 = Hanauer \| first8 = SB. \| last9 = Rycroft \| first9 = B. \| title = Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. \| journal = Clin Gastroenterol Hepatol \| volume = 14 \| issue = 3 \| pages = 348-354.e17 \| month = Mar \| year = 2016 \| doi = 10.1016/j.cgh.2015.06.001 \| PMID = 26071941 }}</ref>		'''Mayo score''' is used by some endoscopists to grade [[inflammatory bowel disease]] activity.<ref name=pmid26071941>{{Cite journal \| last1 = Peyrin-Biroulet \| first1 = L. \| last2 = Panés \| first2 = J. \| last3 = Sandborn \| first3 = WJ. \| last4 = Vermeire \| first4 = S. \| last5 = Danese \| first5 = S. \| last6 = Feagan \| first6 = BG. \| last7 = Colombel \| first7 = JF. \| last8 = Hanauer \| first8 = SB. \| last9 = Rycroft \| first9 = B. \| title = Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. \| journal = Clin Gastroenterol Hepatol \| volume = 14 \| issue = 3 \| pages = 348-354.e17 \| month = Mar \| year = 2016 \| doi = 10.1016/j.cgh.2015.06.001 \| PMID = 26071941 }}</ref>

	==Background==		==Background==

Michael at 18:48, 3 February 2017

2017-02-03T18:48:48Z

← Older revision		Revision as of 18:48, 3 February 2017
Line 13:		Line 13:
	Notes:		Notes:
	*"0" is normal, "1" is mild, "2" is moderate, and "3" is severe.		*"0" is normal, "1" is mild, "2" is moderate, and "3" is severe.

	==See also==		==See also==
	*[[Inflammatory bowel disease]].		*[[Inflammatory bowel disease]].
Line 19:		Line 18:
	==References==		==References==
	{{Reflist\|1}}		{{Reflist\|1}}

	==External links==		==External links==
	*[http://gihep.com/calculators/luminal/mayo-disease-activity/ Mayo score calculator (gihep.com)].		*[http://gihep.com/calculators/luminal/mayo-disease-activity/ Mayo score calculator (gihep.com)].

Michael at 18:47, 3 February 2017

2017-02-03T18:47:59Z

← Older revision		Revision as of 18:47, 3 February 2017
Line 19:		Line 19:
	==References==		==References==
	{{Reflist\|1}}		{{Reflist\|1}}

			==External links==
			*[http://gihep.com/calculators/luminal/mayo-disease-activity/ Mayo score calculator (gihep.com)].

	[[Category:Clinical]]		[[Category:Clinical]]
	[[Category:Gastrointestinal pathology]]		[[Category:Gastrointestinal pathology]]

Michael: /* Details */

2017-02-03T18:45:35Z

Details

← Older revision		Revision as of 18:45, 3 February 2017
Line 12:		Line 12:

	Notes:		Notes:
	*"0" is ~~assigned for~~ normal and "3" ~~for very~~ severe ~~disease~~.		*"0" is normal, "1" is mild, "2" is moderate, and "3" is severe.

	==See also==		==See also==

Michael: create

2017-02-03T18:44:31Z

create

New page

'''Mayo score''' is used by some endoscopists to grade [[ulcerative colitis]] activity.<ref name=pmid26071941>{{Cite journal | last1 = Peyrin-Biroulet | first1 = L. | last2 = Panés | first2 = J. | last3 = Sandborn | first3 = WJ. | last4 = Vermeire | first4 = S. | last5 = Danese | first5 = S. | last6 = Feagan | first6 = BG. | last7 = Colombel | first7 = JF. | last8 = Hanauer | first8 = SB. | last9 = Rycroft | first9 = B. | title = Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. | journal = Clin Gastroenterol Hepatol | volume = 14 | issue = 3 | pages = 348-354.e17 | month = Mar | year = 2016 | doi = 10.1016/j.cgh.2015.06.001 | PMID = 26071941 }}</ref>

==Background==
The system was described in a 1987 article written by Mayo Clinic staff.<ref name=pmid3317057>{{Cite journal | last1 = Schroeder | first1 = KW. | last2 = Tremaine | first2 = WJ. | last3 = Ilstrup | first3 = DM. | title = Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. | journal = N Engl J Med | volume = 317 | issue = 26 | pages = 1625-9 | month = Dec | year = 1987 | doi = 10.1056/NEJM198712243172603 | PMID = 3317057 }}</ref>

==Details==
The system consists for four separate parts:<ref name=pmid3317057/>
#Stool frequency (0-3).
#Rectal bleeding (0-3).
#Endoscopic findings (0-3).
#Physician global assessment (0-3).

Notes:
*"0" is assigned for normal and "3" for very severe disease.

==See also==
*[[Inflammatory bowel disease]].

==References==
{{Reflist|1}}

[[Category:Clinical]]
[[Category:Gastrointestinal pathology]]